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Metastatic progression is the leading cause of mortality in breast cancer. invasive tumor cells develop 
invadopodia to travel through basement membranes and the interstitial matrix. Substantial efforts 
have been made to characterize invadopodia molecular composition. However, their full molecular 
identity is still missing due to the difficulty in isolating them. To fill this gap, we developed a non-
hypothesis driven proteomic approach based on the BioiD proximity biotinylation technology, 
using the invadopodia-specific protein Tks5α fused to the promiscuous biotin ligase BirA* as bait. in 
invasive breast cancer cells, Tks5α fusion concentrated to invadopodia and selectively biotinylated 
invadopodia components, in contrast to a fusion which lacked the membrane-targeting PX domain 
(Tks5β). Biotinylated proteins were isolated by affinity capture and identified by mass spectrometry. 
We identified known invadopodia components, revealing the pertinence of our strategy. Furthermore, 
we observed that Tks5 newly identified close neighbors belonged to a biologically relevant network 
centered on actin cytoskeleton organization. Analysis of Tks5β interactome demonstrated that some 
partners bound Tks5 before its recruitment to invadopodia. Thus, the present strategy allowed us to 
identify novel Tks5 partners that were not identified by traditional approaches and could help get a 
more comprehensive picture of invadopodia molecular landscape.
While primary breast tumor patients can often be cured by surgery and/or radiation therapy combined to chemo-
therapy when detected at early stages, progression of the disease to the metastatic stage is still a major cause of 
patient death. Therefore, deciphering the molecular mechanisms underlying metastatic progression is of crucial 
importance for a better control of the disease. In order to reach the vascular system and be transported to dis-
tant organs and colonize them, tumor cells need to breach through basement membranes and invade through 
the interstitial matrix. Extracellular matrix (ECM) proteolysis is required to clear space and create tracks along 
which cells migrate. Invadopodia, which are dynamic actin-rich protrusive structures that cancer cells develop at 
their surface, play a major role in ECM proteolysis1–3. Furthermore, increasing amount of evidence point to their 
involvement in metastasis4,5. Therefore, a better understanding of their biology and molecular characteristics 
might permit the identification of markers of metastatic propensity and potential therapeutic targets.
Major efforts have been made during the past 25 years to characterize invadopodia molecular composition, 
using classical targeted proteomics involving cell fractionation or co-immunoprecipitation after cell lysis or can-
didate approaches. These studies have established that invadopodia are composed of structural and signaling 
proteins, including cortactin, cofilin, N-WASP and Tks4/5, that control the reorganization of the underlying actin 
cytoskeleton and the release of proteases such as MT1-MMP, involved in matrix degradation1–3. Furthermore, 
time-lapse microscopy analyses revealed that invadopodia formation and maturation involve three major steps: 
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initiation, assembly and maturation6,7. However, the full molecular identity of these structures is missing due to 
the fact that their isolation and purification have been challenging8.
To circumvent these limits, we developed a non-hypothesis driven approach based on the proximity-dependent 
BioID biotinylation assay, coupled to mass spectrometry analysis9. This technique relies on the engineering of 
cells expressing a protein of interest fused to the promiscuous biotin ligase BirA*. In presence of biotin, BirA* 
biotinylates its close protein neighbors in situ, which can then be isolated using avidin-based affinity capture and 
identified by mass spectrometry. Proximity-dependent techniques allow to explore the molecular landscape of 
membrane-less organelles or of protein complexes localized to poorly soluble subcellular compartments, which 
are poorly accessible by more established approaches such as cell fractionation and affinity purification. Moreover, 
they enable the identification of weak or transient protein-protein interactions10,11.
We wished to establish whether proximity labelling could help characterize invadopodia at the molecular 
level. For that purpose, the scaffold protein Tks5, also known as SH3PXD2A or FISH, was used as bait. Indeed, 
in contrast to other invadopodia components which are also components of other actin-based structures such as 
lamellipodia or focal adhesions, Tks5 is specific of invadopodia. Tks5 protein contains five Src Homology 3 (SH3) 
domains, proline-rich regions (PxxP) and, depending on the isoform, a N-terminal phox-homology (PX) domain 
which confers affinity for phosphatidylinositol-3,4-bisphosphate (PI(3,4)P2)12,13. Three Tks5 isoforms have been 
reported arising from distinct promoter usage: Tks5α (also referred as Tks5long), Tks5β and Tks5short14–16. 
Tks5α is the only isoform containing the N-terminal PX domain. In cancer, the expression level of Tks5α or the 
ratio of Tks5α expression to Tks5β/Tks5short expression, rather than the total level of Tks5, is correlated to poor 
prognosis and lower metastasis-free survival in diverse cancer types15,17–20. This is correlated with the fact that 
Tks5α plays a major role in invadopodia formation and cancer cell invasion. Indeed, consequently to its recruit-
ment at PI(3,4)P2-enriched membrane domains, Tks5 potentiates actin polymerization through its interaction 
with the WASP-Arp2/3 complex21. Moreover, Tks5α through direct or indirect recruitment of proteases at inva-
dopodia contributes to ECM degradation22,23. Finally, Tks5 facilitates the local generation of reactive oxygen spe-
cies which are required for podosome (counterpart of invadopodia in normal cells) and invadopodia formation24.
In this study, in order to determine Tks5 interactome in situ and therefore invadopodia molecular compo-
sition, we engineered MDA-MB-231 breast cancer cell lines expressing either Tks5α, or Tks5α lacking the PX 
domain fused to the biotin ligase BirA* and verified that this allowed the biotinylation and identification of 
invadopodia components. Label-free mass spectrometry analysis identified new potential invadopodia proteins 
that formed a protein-protein interaction network of actin cytoskeleton regulators. Tks5α lacking the PX domain 
recruited an overlapping but distinct group of proteins indicating that some proteins associate to Tks5 before its 
recruitment to invadosomes. Thus, the present strategy shows great potential for the molecular characterization 
of invadopodia in situ.
Results
Selective biotinylation of invadopodia proteins by Tks5-BirA* fusion proteins. In order to char-
acterize invadopodia at the molecular level, we set up the identification of the close neighbors of a specific com-
ponent of invadopodia, the adaptor protein Tks5α12, using the BioID proximity ligation technology. We therefore 
stably expressed wild type Tks5α (Tks5) fused to BirA* in MDA-MB-231 breast cancer cells (Fig. 1A). We also 
generated MDA-MB-231 cells expressing a mutant form of Tks5α lacking its PX domain (ΔPX-Tks5) fused to 
BirA* (Fig. 1A). This mutant, mimicking the Tks5β/short form of Tks5, should not localize to invadopodia. 
Tks5β has also been described to have a dominant negative effect over Tks5α15. Finally, cells expressing BirA* 
alone were established as control for identification of unspecific biotinylation. We derived individual clones by 
limiting dilution and selected cells with similar expression levels of the fusion proteins (Fig. 1C). Invasive cells 
form invadopodia when plated on an artificial ECM. Tks5-BirA* fusion proteins or BirA* expressing cells and 
non transfected (NT) cells were seeded on fluorescently-labeled gelatin to visualize invadopodia formation. We 
observed that Tks5-BirA* localized at mature invadopodia, identified by cortactin labeling and gelatin degra-
dation, whereas ΔPX-Tks5-BirA* and BirA* did not (Fig. 1B). Moreover, in accordance with previous stud-
ies, Tks5-BirA* overexpression increased the ability of cells to degrade gelatin13,25. Indeed, we observed an 
increase in the percentage of cells degrading the matrix, but also in the area that was degraded per individual cells 
(Fig. 1B,D,E), while expression of BirA* alone had no effect (data not shown). In contrast, expression of ΔPX-
Tks5 reduced the percentage of degrading cells. These observations demonstrate that Tks5-BirA* fusion proteins 
are functional and that only full-length Tks5-BirA* is strongly enriched in invadopodia.
It was then important to verify that Tks5-BirA* could induce selective biotinylation at invadopodia. Cells 
were seeded on fluorescent gelatin in presence of biotin for 16 hours and localization of biotinylated proteins was 
assessed by staining with streptavidin coupled to Alexa Fluor 594. We observed an accumulation of biotinylated 
proteins at invadopodia in cells expressing Tks5-BirA*, but not in cells expressing the mutant ΔPX-Tks5-BirA* 
or BirA* alone (Fig. 2A and data not shown). In cells expressing ΔPX-Tks5-BirA*, biotinylated proteins were 
exclusively cytoplasmic. Thus this approach was likely to reveal invadopodia components.
Finally, we assessed if previously described partners of Tks5 and invadosomes components, such as N-WASP, 
Nck and Grb221,25, could indeed be biotinylated by Tks5-BirA*. MDA-MB-231 cells expressing Tks5-BirA* 
fusion proteins or BirA* were seeded on gelatin for 16 hours in the presence of biotin. Biotinylated proteins were 
isolated by affinity capture using avidin-coated beads and the biotinylation of the proteins of interest assessed by 
western blotting. N-WASP and Nck were biotinylated by Tks5-BirA* but not, or much less, by ΔPX-Tks5-BirA* 
(Fig. 2B). None of the proteins were biotinylated by BirA*. Thus our approach is capable of identifying bona 
fide Tks5 partners. This result also shows that the interactions of Tks5 with Nck and N-WASP, that have been 
previously identified by co-immunoprecipitation after cell lysis, also occurred in vivo. Furthermore, the fact that 
N-WASP and Nck were poorly biotinylated by ΔPX-Tks5-BirA* strongly suggested that their interaction with 
Tks5 occurred once Tks5 had been recruited at PI(3,4)P2-enriched invadopodia. We cannot totally exclude, 





















































































































Figure 1. Tks5-BirA* is active and localizes in invadopodia. (A) Schematic representation of BirA* fusion 
proteins used in this study. The PX, SH3 and Proline rich (PxxP) domains of Tks5 are depicted. All fusion 
proteins have a HA tag at their C-terminus. (B) Representative images of MDA-MB-231 cells stably expressing 
wild-type Tks5 or Tks5 lacking its PX domain (ΔPX) fused to the biotin ligase BirA* or BirA* alone, and 
of non-transfected (NT) cells, seeded on fluorescently-labeled gelatin (FITC-gelatin) for 4 hours. Cells were 
fixed and stained with anti-HA and -cortactin antibodies. Invadopodia were identified thanks to cortactin 
labeling. Active invadopodia were identified thanks to degradation area (dark spots) in FITC-gelatin. The 
white-boxed regions are shown enlarged in the bottom insets. Scale bars represent 5μm. (C) Expression levels 
of BirA* fusion proteins in MDA-MB-231-derived cells described in (B) was assessed by western blotting using 
an anti-HA antibody. α-Tubulin was used as a loading control. (D,E) Tks5-BirA* fusion proteins are functional. 
The ability of MDA-MB-231 cells expressing Tks5-BirA* fusion proteins, described in (B), to degrade 
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however, that N-WASP and Nck require the presence of the PX domain for the interaction. By contrast, Grb2 was 
not biotinylated by Tks5-BirA* fusion proteins (Fig. 2B). This observation is in agreement with a previous study 
indicating that Grb2 can distinguish between invadopodia and podosomes26. The lack of Grb2 biotinylation could 
also be due to improper relative orientation of the fused proteins and/or inaccessible lysine residues. Altogether 
these observations show that MDA-MB-231 cells expressing Tks5-BirA* and ΔPX-Tks5-BirA* are suitable cell 
models to address invadopodia composition in a global manner.
Tks5α close neighbors belong to an integrative network associated with actin cytoskeleton 
reorganization. Analysis of biotinylation in whole cell extracts or after affinity capture indicated that 
Tks5-BirA* fusion proteins led to high levels of biotinylation of a restricted number of proteins, whereas few 
proteins were biotinylated to detection levels in non-transfected MDA-MB-231 cells or cells expressing BirA* 
alone (Fig. 2C). Silver staining of the proteins pulled down in non-transfected cells or cells expressing BirA* 
revealed a substantial number of proteins binding non-specifically to avidin-coupled beads (Fig. 2D). We next 
conducted mass spectrometry analysis of affinity captured proteins from Tks5-BirA* expressing cells and control 
cells. Relative intensity-based label-free quantification (LFQ) method identified 40 proteins significantly enriched 
with a 1% permutation FDR (pFDR) in Tks5-BirA* pulldown compared to BirA* control pulldown (Fig. 3A and 
Supplementary Table S1).
To assess the biological relevance of this group of proteins, we surveyed the existence of previously described 
functional or physical protein-protein interactions (PPI) among them using the STRING platform. Such an anal-
ysis indicated that the identified Tks5 close neighbors form a significant functional network (PPI enrichment 
p-value =1.54e-09). The significance of this network was even greater when WASL/N-WASP and NCK1/Nck, 
that we validated as close neighbors directly by western blotting (Fig. 2B), were included (PPI enrichment p-value 
=1.17e-14). Application of Markov Clustering logarithm (MCL) revealed that Tks5 close neighbors are organized 
in a main core cluster (Fig. 3B - proteins in red and gold).
We next investigated molecular pathways associated with our biologically relevant network. Gene ontology 
analysis using PANTHER classification system indicated that “actin cytoskeleton organization” (GO: 0030036), 
critical for invadopodia regulation, was the most significantly overrepresented biological process in our network 
compared to its occurrence in the whole human genome (fold enrichment =11.91, P value =2.45e-10) strength-
ening the pertinence of our strategy (Fig. 3C,D).
Furthermore, comparison of Tks5 close neighbors identified in the present study to GLAD4U literature min-
ing protein listing obtained for “invadosome” query and manual literature searching revealed that 17.5% (7 out 
of 40) were previously linked to invadosomes (Fig. 3A – red spots). Most of them have been implicated in inva-
dosomes assembly through regulation of the actin cytoskeleton: Cortactin, a key component of invadopodia, 
which was among the most enriched biotinylated proteins with a fold enrichment (Log2) of 7.5 (Supplementary 
Table S1), is a regulator of Arp2/3 complex activity27; and the Cdc42 guanine exchange factor FGD128,29, the 
formin binding protein FNBP1 (FBP17)30–32, the Ras-associated and pleckstrin homology containing protein 1 
(RAPH1), also known as Lamellipodin (Lpd)33, and the Drebrin-like protein, DBNL (mAbp1)34 were all found 
to regulate invadosome formation through the control of factors implicated in elongation and branching of actin 
filaments. In contrast, the zonula occludens protein ZO-1/TJP1 was proposed to regulate degradative activity of 
invadopodia-like structures through its interaction with ADAM12 and MMP1435,36. The ADAM15 metallopro-
teinase, which was actually suggested to be a Tks5 interactor22,37, since its intracellular domain can associate with 
Tks5, might also function in degradation of the ECM, but, in contrast to ADAM1238,39, its function in invado-
somes remains to be demonstrated. Finally, the RNA binding protein IGF2BP2/IMP2 was shown to be involved in 
invadopodia formation through the control of the stability or localization of mRNAs of factors implicated in cell 
adhesion, mobility, invasion and ECM40,41. We also identified factors that have not been themselves involved in 
invadosome biology, but belong to protein families whose other members have (Fig. 3A – orange spots). Such fac-
tors include the 5′-inositol lipid phosphatase Synaptojanin-142,43, the CIN85/CMS family member CD2AP/CMS44 
and the tight junction protein TJP235,36. Of note, the majority of these proteins constitute the main core cluster 
of the integrative network identified after MCL clustering (Fig. 3B). Additional proteins, including Reticulon-4 
(RTN4)45,46, PDZ and LIM domain protein 4 (PDLIM4/RIL)47,48 and Dihydropyrimidase-like protein 3 (DPYSL3/
CRMP4)49 were integrated to this main core cluster. Interestingly, these proteins, although not currently impli-
cated in invadosome regulation, have been linked to actin cytoskeleton organization. Furthermore, as pointed out 
by the gene ontology analysis and manual literature searching, additional proteins involved in actin cytoskeleton 
organization were identified among Tks5 close neighbors (Fig. 3B – striped circles and Fig. 3D). These include the 
inhibitor of the Arp2/3 complex, Arpin50, the breast cancer anti-estrogen resistance protein 3 (BCAR3)51,52, the 
PDZ and LIM domain protein 1 (PDLIM1/ELFIN)53,54, the SHC-transforming protein 1 (SHC1)55, the LIM and 
Calponin homology domain containing protein 1 (LIMCH1)56, the E3 ubiquitin ligase Mind Bomb 1 (MIB1)57, 
the microtubule-associated protein 4 (MAP4)58 and the anthrax toxin and collagen I receptor, ANTXR1/
TEM859,60. These observations strongly suggest that, through their control of actin organization, these proteins 
could be involved in invadosomes formation.
Thus, although other biological processes such as “D-ribose metabolism” or “tRNA wobble base modifica-
tion”, were found significantly overrepresented by PANTHER classification system, the main pathway represented 
among Tks5 interactome is linked to actin cytoskeleton organization, which is critical for invadopodia regulation 
fluorescently-labeled gelatin was analyzed. The percentage of degrading cells (D) and the degraded area per cell 
(E) are represented as the mean ± SEM of three independent experiments. ***p ≤ 0.001. Full-length blots are 
presented in Supplementary Fig. 2.







































































































































Figure 2. Selective biotinylation of invadopodia proteins by Tks5-BirA*. (A) Representative images of 
MDA-MB-231 cells stably expressing Tks5-BirA* or ΔPX-Tks5-BirA* seeded on fluorescently-labeled gelatin 
(FITC-gelatin) in the presence of biotin for 16 hours. Cells were fixed and stained for cortactin as a marker 
of invadopodia and streptavidin coupled to Alexa Fluor 594 to reveal biotinylated proteins. The white-boxed 
regions are shown enlarged in the bottom insets. Scale bars represent 5μm. (B) Analysis of the biotinylation 
of known Tks5 interactors and of well characterized invadosome components. MDA-MB-231 cells stably 
expressing BirA*, Tks5-BirA* or ΔPX-Tks5-BirA* were seeded on gelatin in presence of biotin for 16 h. 
After cell lysis, biotinylated proteins were isolated by affinity capture using avidin-coated beads. The presence 
of proteins of interest was assessed in whole cell extract (WCE) or after avidin-based pulldown by western 
blotting with specific antibodies. (C) Isolation of proteins biotinylated by Tks5-BirA* and ΔPX-Tks5-BirA*. 
MDA-MB-231 cells stably expressing Tks5-BirA*, ΔPX-Tks5-BirA* or BirA*, and non-transfected (NT) cells 
were seeded on gelatin and treated with biotin for 16 h before cell lysis. Biotinylated proteins were pulled down 
via avidin-coated beads. The presence of biotinylated proteins was assessed by western blotting in whole cell 
extract (WCE) or after avidin-based pulldown (one-twentieth of the total pulldown was used) using HRP-
coupled streptavidin. (*) corresponds to intrinsically biotinylated proteins. (D) One-tenth of the samples shown 
in (C) was resolved by SDS-PAGE for silver staining of the isolated proteins; the rest was analyzed by mass 
spectrometry. Full-length blots/gels are presented in Supplementary Fig. 2.
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Figure 3. Tks5α close neighbors belong to an integrative network related to actin cytoskeleton reorganization. 
MDA-MB-231 cells expressing Tks5-BirA* or BirA* were seeded on gelatin-coated plates and treated with 
biotin for 16 h. Biotinylated proteins were isolated by affinity capture and identified by mass spectrometry. (A) 
Volcano plot showing the differential level (Log2) and the p-value (-Log10), on x and y axis, respectively, for 
Tks5-BirA* versus BirA*. The full line is indicative of protein hits obtained at a permutation false discovery 
rate (pFDR) of 1%. Data result from two different experiments processed three times. Red and orange spots 
highlight proteins previously associated with invadosomes and proteins for which a family member has been 
associated with invadosomes, respectively. Green spots highlight proteins associated with cancer invasion/
metastasis, outside of invadosome-associated proteins. For more details, refer to Supplementary Table S1. (B) 
Proteins biotinylated by Tks5-BirA*, including the validated candidate proteins (WASL and NCK1 which 
appear in italic) were integrated in a protein-protein interaction network based on physical and functional 
interactions per the STRING database. Markov Clustering algorithm has been applied. Proteins belonging 
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(Fig. 3C). Furthermore, a large fraction (more than 50%) of Tks5 close neighbors identified here (Fig. 3A and 
Supplementary Table S1) is associated with cancer cell invasion and metastasis.
Invadopodia components show different modes of interaction with Tks5. To obtain further 
insights in the comprehension of invadopodia formation, we took advantage of the cellular model expressing 
the short form of Tks5, deleted of its PX domain (ΔPX-Tks5) (Fig. 1). PX domains mediate interactions with 
specific membrane phosphoinositides. Tks5 PX domain was reported to preferentially interact with PI(3)P and 
PI(3,4)P222. Such interaction contributes to Tks5 activation and thus to podosomes and invadopodia forma-
tion13,21,61. Our cellular model could therefore help us differentiate factors that associate with Tks5 before its 
recruitment to invadosome precursors, from those that associate with Tks5 at invadosome precursors. We there-
fore analyzed mass spectrometry data resulting from ΔPX-Tks5-BirA* pulldowns and identified 44 enriched 
proteins at 1% pFDR in ΔPX-Tks5-BirA* pulldown relatively to BirA* control pulldown (Supplementary 
Table S2). We then intersected this list of proteins with the in situ Tks5 interactome (Fig. 4A and Supplementary 
Table S3). Twenty-seven proteins were shared (Fig. 4A - red spots and Supplementary Table S3), correspond-
ing to more than half of the total proteins identified in each condition (67.5% and 61.3% of Tks5-BirA*- and 
ΔPX-Tks5-BirA*-associated proteins respectively). Some proteins were similarly enriched in the Tks5-BirA*- 
and ΔPX-Tks5-BirA*-associated groups, including the key invadopodia component Cortactin. Western 
blotting after pulldown of biotinylated proteins confirmed that Cortactin was biotinylated at similar levels 
by Tks5-BirA* and ΔPX-Tks5-BirA*, indicating that Cortactin is in the vicinity of Tks5 independently of 
its presence at invadopodia (Fig. 4B). Many proteins were found exclusively or more strongly associated with 
Tks5-BirA* than ΔPX-Tks5-BirA*, among which thirteen were specifically biotinylated by Tks5-BirA*, but not 
by ΔPX-Tks5-BirA* nor BirA* (Fig. 4A - blue spots and Supplementary Table S3). RTN4, FGD1 and SHC1 were 
among the most highly enriched (Difference (Log2)>3.35). We confirmed by western blotting after pulldown 
of biotinylated proteins that RTN4 and FGD1 were specifically biotinylated by Tks5-BirA* (Fig. 4B) and that 
SHC1, MAP4 and CD2AP/CMS were biotinylated by both fusion proteins, but were more tightly associated with 
Tks5-BirA* (Fig. 4B). We can speculate that the interaction of SHC1, MAP4 and CD2AP is stabilized once Tks5 
is recruited to PI(3,4)P2-enriched domains. Finally, for some of the shared proteins, fold enrichment was higher 
with ΔPX-Tks5-BirA* than with Tks5-BirA*, in accordance with the proposed mechanism whereby ΔPX-Tks5 
might inhibit invadosome formation by mislocalizing actin-regulatory proteins62. One might be concerned that 
expression of endogenous Tks5 might compete with Tks5-BirA* fusion proteins, disturbing full interaction with 
their partners; however we have verified that biotinylation of all validated partners is unchanged upon endog-
enous Tks5 knockdown (Sup.Fig. 1). Overall the comparison of Tks5α and Tks5β (ΔPX-Tks5) interactomes 
identifies three groups of Tks5 partners: (1) those interacting with Tks5 before its recruitment to PI(3,4)P2-rich 
domain, (2) those interacting weakly with Tks5 before its recruitment to PI(3,4)P2-rich domain, but whose inter-
action is stabilized once Tks5 is recruited, and (3) those interacting with Tks5 at invadopodia.
Finally, we wished to verify if newly identified Tks5 partners, for which we identified antibodies suitable for 
immunofluorescence staining, localized to invadopodia. As invadopodia labelling for proteins that are also highly 
expressed in the cytoplasm, such as the endoplasmic reticulum-associated RTN4/Nogo-B or the cytosolic scaffold 
SHC1, was challenging, we adapted a protocol for immunostaining after removal of the cell body by hypotonic 
shock and hydrodynamic force63, preserving only the invadopodia within the gelatin matrix. We observed that 
RTN4/Nogo-B and SHC1 could localize at mature invadopodia, after removal of the cell body, but also in intact 
cells (Fig. 5). In contrast, MAP4 does not seem to localize at invadopodia (data not shown). However, RTN4/
Nogo-B and SHC1 were found less often at degradation foci than cortactin or the metalloprotease MT1-MMP, 
indicating that their presence at invadopodia might be transient. This suggests that these proteins, rather than 
being constitutive invadopodia components, might have a stage-specific regulatory function.
Discussion
Invadopodia, actin-rich protrusive structures developed at cancer cells surface in order to degrade the surround-
ing ECM1–3, are correlated to the metastatic potential of diverse cancer types, hence the importance of better 
understanding their biology4,5. In the current study, in order to gain insights into invadopodia molecular land-
scape, we determined the in situ interactome of Tks5, a key player in invadosome formation, by a global approach 
based on proximity-dependent labeling. Previous studies have identified Tks5 interacting partners21,22,25,59 using 
conventional approaches, based on identification of proteins co-precipitating with Tks5 or Tks5 domains, e.g. 
the SH3 domains. Proximity-dependent labeling methods in living cells are powerful technologies that allow to 
explore protein-protein interactions (PPI), or at least protein-protein close proximity, in situ, before cell lysis. 
Unlike more classical approaches, it allows to identify PPI in more physiologically relevant conditions, low affin-
ity and/or transient PPI, as well as the proteome of membrane-less organelles and subcellular domains10,11. We 
to a same cluster have an identical color; the main core cluster is in red and gold. Line thickness indicates the 
strength/confidence of data support. Dotted lines mark the edges of the clusters. Among disconnected proteins, 
factors linked to actin organization are striped. The bait Tks5/SH3PXD2A is highlighted in bold. (C) Treemap 
representing the top biological processes represented among proteins biotinylated by Tks5-BirA*, as defined 
in (B), using PANTHER classification system for analysis and REVIGO for summarization and visualization. 
Each rectangle is a single cluster representative. The representatives are joined into ‘superclusters’ of loosely 
related terms, visualized with different colors. Size of the rectangles reflects the p-value of the GO term. (D) 
Proteins biotinylated by Tks5-BirA* (B) categorized as GO “Actin cytoskeleton organization” by PANTHER 
classification system.
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choose to fuse Tks5 to the promiscuous biotin ligase BirA*. Fusion of BirA* to Tks5 did not affect its function: it 
was strongly enriched in invadopodia and promoted invadopodia formation and activity (Fig. 1). Biotinylation is 
supposed to occur within an estimated range of 10nm64. Thus Tks5-BirA* should mostly biotinylate direct part-
ners of Tks5, and proteins that belong to invadopodia, which have an estimated diameter of 0.05 to 1μm. We ver-
ified that Nck and N-WASP, invadopodia proteins and co-precipitation partners of Tks5, are indeed biotinylated 
by Tks5-BirA*, but only when present at invadopodia (Fig. 2). This result also confirms that these interactions 
actually take place in intact cells.
Mass spectrometry analysis identified at least 40 proteins significantly associating with Tks5 (Fig. 3 and 
Supplementary Table S1). A large number of the identified proteins are part of a functionally and physically-linked 
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Figure 4. Invadopodia components show different modes of interaction with Tks5. MDA-MB-231 cells 
expressing Tks5-BirA*, ΔPX-Tks5-BirA* or BirA* were seeded on gelatin-coated plates and treated with 
biotin for 16 h. Biotinylated proteins were isolated by affinity capture and identified by mass spectrometry. 
(A) Volcano plot showing the differential level (Log2) and the p-value (-Log10), on x and y axis, respectively, for 
Tks5-BirA* versus ΔPX-Tks5-BirA*, without taking into account proteins identified as biotinylated in BirA* 
control condition. Data result from two different experiments processed three times. Proteins biotinylated 
by Tks5-BirA*, by ΔPX-Tks5-BirA* and by both Tks5-BirA* and ΔPX-Tks5-BirA*, relative to the BirA* 
control condition, are highlighted in blue, green and red, respectively. For more details refer to Supplementary 
Table S3. (B) Verification of the biotinylation levels induced by Tks5-BirA* or ΔPX-Tks5-BirA*, of selected 
proteins identified in (A). The presence of proteins of interest was assessed in whole cell extract (WCE) or after 
avidin-based pulldown followed by western blotting with the indicated antibodies. Dotted lines indicate that 
the disposition of the lanes has been reorganized, but that lanes are from a single blot and are therefore directly 
comparable. Full-length blots are presented in Supplementary Fig. 2.
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linked to invadosomes and more than 50% are involved in cancer invasion and metastasis, revealing Tks5 in situ 
interactome as a source of potential new invadopodia components and regulators and strengthening the relevance 
of our approach. Very few studies have addressed the proteome of invadosomes, as their isolation and purification 
have been challenging. Two strategies have been used before: either cell fractionation by mechanical removal of 
the cell bodies in the case of invadopodia and podosomes65,66 or laser microdissection in the case of Src-induced 
rosettes67. Although our list of proteins shares only few proteins with these studies (none with Attanasio et al., 
1 with Cervero et al., 5 with Ezzoukhry et al.), a common feature between these studies and our results is the 
overrepresentation of factors involved in actin cytoskeleton organization (Fig. 3). We could also identify proteins 



















































Figure 5. RTN4/Nogo-B and SHC1, newly identified Tks5 close neighbors, localize at a subset of mature 
invadopodia. Representative images of MDA-MB-231 cells stably expressing Tks5-BirA* seeded on 
fluorescently-labeled gelatin (FITC-gelatin) for 4 hours. In the “Whole cell” condition, cells were kept intact, 
whereas in the “Invadopodia” condition, cell bodies were removed by hypotonic shock and hydrodynamic force, 
before fixation. Cells were stained with the indicated antibodies. Cortactin being a constitutive component of 
invadopodia, cortactin staining (in blue) was used as a control. Scale bars represent 2.5 μm.
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categories of proteins were highly enriched, they were poorly represented in our study. These differences might be 
linked to the strategy used. Whereas classical proteomic approaches catched a snapshot of invadosomes protein 
composition, proximity biotinylation captured Tks5 neighbors over an extended period (16 h), which should also 
reveal transiently associated proteins. Actually, partial co-localization of RTN4/Nogo-B and SHC1 with mature 
invadopodia suggests that they might only transiently associate with Tks5, at a specific step of invadopodia life-
time (Fig. 5). Moreover, whereas previous studies were based on cellular fractionation of the whole invadosomes, 
our strategy is focused on the identification of partners of a particular invadopodia protein. Considering the 
volume of an invadopodia, invadopodia components are not necessarily in the vicinity of Tks5, and one does not 
expect a complete overlap between Tks5 interactome and the invadopodia proteome. Tks5 being usually depicted 
as localizing in the functional core of invadosomes in close proximity of factors regulating actin polymerization 
and ECM degradation, it is not surprising to predominantly identify factors linked to these processes among 
Tks5 close neighbors. Even though the biotinylation radius of BirA* is low, we cannot exclude that some of the 
proteins identified in Tks5 neighborhood, might be indirect partners. However, assessing molecular organization 
of Tks5 close neighbors using InterPro database, we observed that 17 out of 40, including the known invadopodia 
components FGD1, RAPH1 and FNBP1, contain either Pro-rich regions or SH3 domains, that could mediate a 
direct interaction with Tks5 (Supplementary Table S1). Further studies will be necessary to address their specific 
mode of interaction.
Assembly of invadopodia is a sequential process starting with the formation of an invadopodium precursor 
that will be stabilized and finally mature into a degradation-competent invadopodium1,6,7. Tks5 plays a major role 
in the stabilization step through interaction of its PX domain to PI(3,4)P2-enriched domains, and as a scaffold 
protein allowing the recruitment of factors necessary for invadopodium maturation61. Our comparison of the in 
situ interactomes of Tks5α (Tks5) and of its short form Tks5β (ΔPX-Tks5) suggests that, additionally to acting 
as a scaffolding factor in invadopodia-to-be PI(3,4)P2-rich domains, Tks5 associates with key invadopodia reg-
ulators, e.g. Cortactin, independently of its recruitment to invadopodia. Although these results allow us to get a 
first insight into the molecular mechanism of recruitment of proteins found in the vicinity of Tks5, further work 
would be necessary to address the spatiotemporal organization of invadopodia.
Overall, the present study demonstrates that proximity-dependent labeling methods in living cells are suitable 
to get an insight of invadopodia molecular composition. Indeed, we identified known invadopodia components/
regulators and new potential invadopodia players for which validation of their implication in invadopodia activity 
and eventually in metastases formation, is needed. However, the fact that we did not identify Nck and N-WASP 
in the global strategy, while we identified them as Tks5 close neighbors by a targeted strategy, points to limits in 
sensitivity of our strategy and suggest possible routes of improvements. Several options are under investigation to 
increase the sensitivity of mass spectrometry detection, including the use of a more efficient promiscuous biotin 
ligase (e.g. TurboID) or the enhancement of the biotinylation range through the expansion of the linker region 
between the enzyme and the bait68,69. These strategies combined to the identification of the in situ protein neigh-
bors of additional specific invadopodia components, such as Tks4, would permit to get a larger coverage of the 
invadopodia proteome. We can also envision to use such proximity-dependent labeling approaches to study the 
molecular composition of podosomes developed by normal cells and of the various types of invadopodia cancer 
cells differentially assemble during the invasion process, depending on the matrix environment70,71. The slow 
kinetics of BirA* precludes its use for studying the dynamic molecular organization of invadopodia which have a 
lifetime in the order of one hour. Dynamics could be addressed by next generation proximity-dependent labeling 
techniques, such as the modified peroxidase APEX2 or TurboID, that might allow to resolve spatiotemporal reg-
ulation of invadopodia at the minute-scale68,72. The very existence of invadopodia or invadopodia-like structure 
in a physiological context, i.e. during tumor cell invasion, has been debated for years. As proximity-dependent 
approaches can also be applied in vivo73–75, our study opens the door to the development of proximity-dependent 
labeling approaches in in vivo models of invasion more relevant to metastatic progression.
Materials and Methods
cell lines. MDA-MB-231 cells were cultured in Dulbecco’s Modified Eagle Medium (Thermo Fisher), supple-
mented with 10% fetal bovine serum (Eurobio, Courtaboeuf, France) at 37 °C in a humidified atmosphere with 
5% CO2 and checked regularly for mycoplasma contamination. Stable MDA-MB-231 cell lines were generated 
by transfection of the BirA* plasmid constructs by Lipofectamine 2000 (Invitrogen) and selection with 1 mg/ml 
geneticin. Individual clones were generated by limiting dilution. Ten to twenty clones were screened for BirA* 
fusion proteins expression levels. The degradative activity of three to four clones with different expression levels 
for each BirA* fusion protein was assessed to verify that Tks5 fusion proteins actually promoted (Tks5-BirA*) 
or inhibited (ΔPX-Tks5-BirA*) cell degradative activity. Clones expressing similar levels of the transgenes were 
selected for further analysis.
plasmid constructs. Wild type Tks5 and the mutant Tks5 lacking its PX domain, without stop codon, 
were amplified by PCR from peGFP-N1-Tks5 (a kind gift from S. Courtneidge) with appropriate primers 
(Supplementary Table S4), used to generate pDONR-Tks5 and pDONR-ΔPX-Tks5, respectively before their sub-
cloning in the destination vector pcDNA3.1 MCS-BirA(R118G)-HA (modified from Addgene plasmid # 36047, 
a kind gift from K. J. Roux) by Gateway technology to obtain Tks5 and ΔPX-Tks5 fused to the N-terminus of 
BirA*-HA. All constructs were sequence verified.
Antibodies. Rabbit antibodies against Tks5 (M-300), MAP4 (H-300), HA (Y-11) and mouse antibody against 
Grb2 (C-7) were purchased from Santa Cruz Biotechnology. Mouse antibody against Cortactin (clone 4F11) was 
purchased from Millipore. Antibodies against N-WASP (mouse, ab56454), NogoA/B (rabbit, ab47085), CD2AP 
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(rabbit, ab205017), MMP14/MT1-MMP (rabbit, ab51074) and MRE11 (mouse, ab214) were from Abcam. Rabbit 
antibody against SHC1 (610081) and mouse antibodies against Nck (610099) and SHC1 (610879) were from BD 
Transduction Laboratories. Anti-α-Tubulin (mouse, clone DM1A) and anti-FGD1 (rabbit, HPA000911) were 
from Sigma Life Science. Biotinylated proteins were detected either by Alexa Fluor594 Streptavidin (405240, 
BioLegend) or Streptavidin-HRP (21130, Thermo Scientific).
proximity biotinylation. Cells stably expressing BirA* fusion proteins were seeded on gelatin-coated plates 
and treated overnight with 50 μM biotin, then lysed in a buffer composed of 50 mM Tris pH 7.4, 500 mM NaCl, 
0.4% SDS, 2% Triton X-100, 5 mM EDTA and 1 mM DTT supplemented with protease and phosphatase inhibi-
tors. Biotinylated proteins were isolated by incubating the cell lysates with Avidin-coated beads (Thermo Fisher) 
for 1 h at 4 °C. After three washes with lysis buffer and one wash with 50 mM Tris pH 7.4 plus 50 mM NaCl, beads 
were resuspended in SDS loading buffer supplemented with 2 mM D-biotin (Invitrogen).
Western blotting. After protein extracts preparation, quantification and denaturation in SDS loading buffer, 
samples were run on Novex NuPAGE Bis-Tris 4–12% gels using a MOPS based running buffer. Proteins were 
transferred onto nitrocellulose membranes, incubated with primary antibodies and secondary antibodies coupled 
to HRP and detected by chemoluminescence.
Mass spectrometry analysis. Biological samples were prepared in duplicate and each sample was fur-
ther analyzed thrice by liquid chromatography (LC)-tandem mass spectrometry (MS/MS). Protein extracts 
were stacked on NuPAGE 4–12% Bis-Tris acrylamide gels (Life Technologies) and cut from the gel. Gels pieces 
were submitted to an in-gel trypsin digestion76. Pooled extracts were dried down in a centrifugal vacuum system 
and samples were reconstituted and analyzed by LC-MS/MS using an LTQ Velos Orbitrap Mass Spectrometer 
(Thermo Electron, Bremen, Germany) online with an Ultimate 3000RSLCnano chromatography system (Thermo 
Fisher Scientific, Sunnyvale, CA). Peptides were separated on a Dionex Acclaim PepMap RSLC C18 column 
(15 cm × 75 µm I.D, 100 Å pore size, 2 µm particle size) at 300 nL/min flow rate. Peptides were eluted by a two 
steps linear gradient (4–22% acetonitrile/H2O; 0.1% formic acid for 110 min and 22–32% acetonitrile/H2O; 0.1% 
formic acid for 10 min). For peptide ionization in the EASY-Spray nanosource, spray voltage was set at 1.9 kV at 
275 °C. MS spectra were acquired in the Orbitrap in the range of m/z 300–1700 at a FWHM resolution of 30 000 
and using the 445.120025 ions as internal mass calibration. Collision-induced dissociation fragmentation was 
performed in the ion trap on the 10 most intense precursor ions. The signal threshold for an MS/MS event was 
set to 500 counts. Dynamic exclusion was enabled with a repeat count of 1, exclusion list size 500 and exclusion 
duration of 30 s.
Protein identification and quantification. Relative intensity-based label-free quantification (LFQ) was 
processed using MaxQuant, version 1.6.3.477,78 using mainly default parameters. The acquired raw LC-MS/MS 
data were first processed using the integrated Andromeda search engine79. Spectra were searched against the 
Human database (UniProt Proteome reference, date 2019.01; 20412 entries) supplemented with a set of 245 fre-
quently observed contaminants. The match between runs option was enabled to transfer identifications across 
different LC-MS/MS replicates based on their masses and retention time using default parameters. The quan-
tification was performed using a minimum ratio count of 1 (unique+razor) and the second peptide option to 
allow identification of two co-fragmented co-eluting peptides with similar masses. For identification, the false 
discovery rate (FDR) at the peptide and protein levels were set to 1%. The statistical analysis was done with 
Perseus program (version 1.6.1.3) (http://www.maxquant.org) using LFQ normalised intensities. First, proteins 
marked as contaminant, reverse hits, and “only identified by site” were discarded. Protein LFQ normalized inten-
sities were base 2 logarithmized to obtain a normal distribution. Quantifiable proteins were defined as those 
detected in at least 70% of the samples in one or more condition. Missing values were replaced using data impu-
tation using default parameters. Differential proteins were selected using a two-sample t-test using permutation 
based FDR-controlled at 0.01 and employing 250 permutations. The p value was adjusted using a scaling factor 
s0 with a value of 180. The mass spectrometry proteomics data, including search results, has been deposited to 
the ProteomeXchange Consortium (www.proteomexchange.org)81 via the PRIDE82 partner repository with the 
dataset identifier PXD015847.
proteome analysis. Gene ontology (GO) and enrichment analyses were performed using the Protein 
Analysis Through Evolutionary Relationships (PANTHER 14.1) (http://pantherdb.org/)83,84 using the whole 
human genome as background. REVIGO web server was used to summarize and visualize GO terms (http://
revigo.irb.hr/)85. Interaction network were generated using STRING’s website (version 11.0) at high confidence 
(0.7) and network was clustered using a Markov Clustering algorithm “MCL inflation parameter = 3” (https://
string-db.org/)86,87.
Matrix degradation assay, cell fractionation and immunofluorescence. Acid-treated coverslips 
were incubated with 50 μg/ml poly-D-lysine 20 min at 37 °C, then with 0.5% glutaraldehyde 15 min at room 
temperature (RT) and then inverted on a 40 μl drop of 0.2% gelatin plus Oregon Green 488–conjugated gelatin 
(Life Technologies) (10:1) mixture 10 min at RT. The gelatin matrix was then quenched with 5 mg/ml sodium 
borohydride 5 min at RT and dehydrated in 70% EtOH for storage. Thirty thousand MDA-MB-231 cells were 
plated for 4 h on gelatin-coated coverslips rehydrated in complete growth medium for 1 h before use. For removal 
of the cell bodies, cells were incubated within 2.5 mM Triethanolamine hypotonic buffer for 3 min, then cell 
bodies were removed with hydrodynamic force by the pipetting “up and down” of cold PBS plus inhibitors of 
proteases and phosphatases for 20–25 times, before a final wash with the same solution and fixation. This protocol 
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is adapted from Kuo et al.63. Cells were then fixed with 4% formaldehyde in PBS, permeabilized with 0.1% Triton 
X-100 and blocked with 1% BSA. Immunolabeling was performed with antibodies directed against target proteins 
and secondary antibodies labeled with DyLight 405 or AlexaFluor 594 (Jackson ImmunoResearch). Images were 
acquired on a Zeiss structured light ApoTome microscope equipped with a 63×1.4 Plan-Apochromat objective. 
Percentage of cells degrading was assessed by imaging 10 random fields per condition. Matrix degradation was 
analyzed by quantifying the mean degraded area in pixels per cell using a home-made Fiji macro. Twenty-five 
cells per condition per experiment were analyzed to quantify matrix degradation.
Statistical analysis. All statistical analyses were performed using GraphPad Prism software. The unpaired 
one-tailed t test, with Welch correction, and the Mann Whitney test, were used to determine significant differ-
ences between data groups. Graphs were plotted using Prism, to show the mean and SEM. P values are indicated 
on the graph as *P < 0.05, **P < 0.01, ***P < 0.001.
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